CA1070299A - Stabilized solid form choline salicylate compositions - Google Patents

Stabilized solid form choline salicylate compositions

Info

Publication number
CA1070299A
CA1070299A CA260,766A CA260766A CA1070299A CA 1070299 A CA1070299 A CA 1070299A CA 260766 A CA260766 A CA 260766A CA 1070299 A CA1070299 A CA 1070299A
Authority
CA
Canada
Prior art keywords
salicylate
choline
carboxy
choline salicylate
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA260,766A
Other languages
English (en)
French (fr)
Inventor
Ernest J. Sasmor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Frederick Co
Original Assignee
Purdue Frederick Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/705,056 external-priority patent/US4067974A/en
Application filed by Purdue Frederick Co filed Critical Purdue Frederick Co
Application granted granted Critical
Publication of CA1070299A publication Critical patent/CA1070299A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA260,766A 1976-01-21 1976-09-08 Stabilized solid form choline salicylate compositions Expired CA1070299A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65111076A 1976-01-21 1976-01-21
US05/705,056 US4067974A (en) 1976-01-21 1976-07-14 Stabilized solid form choline salicylate compositions

Publications (1)

Publication Number Publication Date
CA1070299A true CA1070299A (en) 1980-01-22

Family

ID=27096002

Family Applications (1)

Application Number Title Priority Date Filing Date
CA260,766A Expired CA1070299A (en) 1976-01-21 1976-09-08 Stabilized solid form choline salicylate compositions

Country Status (23)

Country Link
JP (1) JPS6051449B2 (es)
AR (1) AR217249A1 (es)
AU (1) AU511510B2 (es)
CA (1) CA1070299A (es)
CH (1) CH635816A5 (es)
DD (1) DD128908A5 (es)
DE (2) DE2701553A1 (es)
DK (1) DK149804C (es)
EG (1) EG12511A (es)
ES (1) ES454712A1 (es)
FI (1) FI56770C (es)
FR (1) FR2338705A1 (es)
GB (2) GB1575978A (es)
GR (1) GR62110B (es)
HU (1) HU175973B (es)
IL (1) IL50992A (es)
MX (1) MX5920E (es)
NL (1) NL183821C (es)
NO (1) NO145295C (es)
NZ (1) NZ182810A (es)
RO (1) RO71764A (es)
SE (1) SE418799B (es)
YU (1) YU40159B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043168A (en) * 1990-04-26 1991-08-27 Sidmak Laboratories, Inc. Solid choline magnesium salicylate composition and method of preparing same
US5217965A (en) * 1991-06-17 1993-06-08 Euroceltique, S.A. Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions
USD850006S1 (en) 2017-11-27 2019-05-28 Mary Kay Inc. Cosmetic compact
USD863685S1 (en) 2017-11-27 2019-10-15 Mary Kay Inc. Cosmetic compact
USD843660S1 (en) 2017-11-27 2019-03-19 Mary Kay Inc. Cosmetic compact

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3347744A (en) * 1963-10-25 1967-10-17 Smith Kline French Lab Magnesium hydroxide suspensions
US3297529A (en) * 1964-11-25 1967-01-10 Sutton Lab Inc Magnesium sulfate stabilized choline salicylate
US3326760A (en) * 1966-05-17 1967-06-20 Synergistics Inc Choline salicylate polygalacturonate therapy
US3759980A (en) * 1969-05-26 1973-09-18 Stockton Chemicals Inc Salicylates

Also Published As

Publication number Publication date
HU175973B (en) 1980-11-28
RO71764A (ro) 1980-10-30
IL50992A0 (en) 1977-01-31
FR2338705A1 (fr) 1977-08-19
YU40159B (en) 1985-08-31
IL50992A (en) 1980-06-30
YU6977A (en) 1982-10-31
SE418799B (sv) 1981-06-29
NL183821B (nl) 1988-09-01
NO770172L (no) 1977-07-22
AU2141977A (en) 1978-07-27
NZ182810A (en) 1979-12-11
DK21677A (da) 1977-07-22
AR217249A1 (es) 1980-03-14
NL183821C (nl) 1989-02-01
DE2701553C2 (es) 1987-11-12
GB1575977A (en) 1980-10-01
ES454712A1 (es) 1977-12-01
DE2760284C2 (es) 1990-08-02
GR62110B (en) 1979-02-26
MX5920E (es) 1984-08-28
NO145295C (no) 1982-02-24
DK149804C (da) 1987-03-09
NL7700514A (nl) 1977-07-25
SE7614538L (sv) 1977-07-22
FI56770C (fi) 1980-04-10
EG12511A (en) 1979-06-30
DD128908A5 (de) 1977-12-14
FI763741A (es) 1977-07-22
CH635816A5 (en) 1983-04-29
GB1575978A (en) 1980-10-01
JPS5294414A (en) 1977-08-09
AU511510B2 (en) 1980-08-21
NO145295B (no) 1981-11-16
DK149804B (da) 1986-10-06
DE2701553A1 (de) 1977-07-28
FI56770B (fi) 1979-12-31
JPS6051449B2 (ja) 1985-11-14
FR2338705B1 (es) 1980-04-04

Similar Documents

Publication Publication Date Title
CA1040532A (en) Process for producing solid bismuth-containing pharmaceutical compositions
US4956386A (en) Pharmaceutical compositions and process for their preparation
IE870120L (en) Histamine h2-antagonist compositions.
KR910000138A (ko) 약제학적 조성물
CZ288545B6 (cs) Stabilizovaná farmaceutická kompozice na bázi kyseliny (E)-3,5-dihydroxy-7-[4´-4´´-fluorfenyl-2´-cyklopropylchinolin-3´-yl]-6-heptenové
CA2083683C (en) Stable formulation of analapril salt, a process for the preparation thereof and the use thereof
RU2153330C2 (ru) Шипучий гранулят и способ его получения
CA1070299A (en) Stabilized solid form choline salicylate compositions
US4067974A (en) Stabilized solid form choline salicylate compositions
Neuman et al. The surface chemistry of bone. IX. Carbonate: phosphate Exchange1
JPH05503540A (ja) 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法
JP2821803B2 (ja) 新規物理化学的特性を有するモノ―（２―アンモニウム―２―ヒドロキシメチル―１，３―プロパンジオール）（２ｒ，シス）―１，２―エポキシプロピルホスホネートならびにその製法
US3361769A (en) Bi-metallic salts of gluconic, glucuronic, or galacturonic acid
JP2809971B2 (ja) 血液透析用製剤
ZA200509026B (en) Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
US4465838A (en) Oxaprozin calcium salt
CA1136550A (en) Pharmaceutical composition containing thymidine
Mitchell The preparation and characterization of ferrous sulphate hydrates
US4338311A (en) Hydrophilic choline salicylate formulation
LT3394B (en) Inclusion complexes of n-ethoxycarbonyl-3-morpholinosydnonimine or salts formed with cyclodextrine-derivatives, preparation thereof and pharmaceutical compositions containing the same a
US3947491A (en) Stabilized choline salicylate compounds
JP2594395B2 (ja) アズレンスルホン酸ナトリウムの安定化法および製剤
IE45202B1 (en) Solid choline salicylate compositions
MY101266A (en) Pharmaceutical formulations
US3109019A (en) Process for preparing a water-soluble sodium salt of acetylsalicylic acid

Legal Events

Date Code Title Description
MKEX Expiry